论文部分内容阅读
目的探讨宫腔镜治疗黏膜下子宫肌瘤的临床疗效与安全性。方法对经B超与宫腔镜联合检查确诊为黏膜下子宫肌瘤的87例患者资料进行回顾性分析,87例患者均行经宫颈宫腔镜下肿瘤切除术,术后随访1～3年,从残余肌瘤再生情况、月经状况有无改善、是否需要二次手术分析手术疗效,从并发症发生情况分析手术安全性。结果 87例患者术中B超和宫腔镜检查、病理送检均证实为黏膜下子宫肌瘤,其中0型患者46例,Ⅰ型患者32例,Ⅱ型患者9例。术中术后无子宫出血、穿孔、水中毒等,安全性高。87例患者术后月经均有不同程度改善,无再次手术病例,残余肌瘤再生不显著,疗效肯定。结论宫腔镜治疗黏膜下子宫肌瘤具有高效、安全等优点,值得临床推广。
Objective To investigate the clinical efficacy and safety of hysteroscopic treatment of submucosal uterine fibroids. Methods The data of 87 patients diagnosed as submucous myoma of uterus by B-ultrasound combined with hysteroscopy were retrospectively analyzed. All of the 87 patients underwent hysteroscopic resection of cervix tumor. The patients were followed up for 1 to 3 years, Residual fibroids from the regeneration of the situation, whether the improvement of menstrual status, whether the need for secondary surgery to analyze the effect of surgery, complications from the analysis of surgical safety. Results 87 cases of intraoperative ultrasound and hysteroscopy, pathological examination were confirmed submucosal uterine fibroids, of which 46 cases of type 0 patients, 32 cases of type I, 9 cases of type II patients. No intraoperative uterine bleeding, perforation, water poisoning, high safety. 87 cases of patients with postoperative menstruation have improved to varying degrees, no cases of reoperation, residual fibroids regeneration is not significant, the effect is sure. Conclusion Hysteroscopic treatment of submucosal uterine fibroids with high efficiency, safety and other advantages, it is worth clinical promotion.